VAN LUNSEN GIL J 4
4 · ARRAY BIOPHARMA INC · Filed Sep 21, 2018
Insider Transaction Report
Form 4
VAN LUNSEN GIL J
Director
Transactions
- Exercise/Conversion
Common Stock
2018-09-19$5.95/sh+18,000$107,100→ 37,297 total - Sale
Common Stock
2018-09-19$14.76/sh−18,000$265,684→ 19,297 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-09-19−18,000→ 0 totalExercise: $5.95Exp: 2026-10-27→ Common Stock (18,000 underlying)
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported for these shares is the weighted average sale price of transactions made at prices from $14.575 to $14.80. Details of actual prices for shares sold are available from the Issuer upon request.
- [F3]Options vested on October 27, 2017.